Project: AD Shield – presymptomatic Alzheimer’s disease detection & prevention of citizens at high risk

Acronym AD Shield (Reference Number: 12748)
Duration 01/04/2019 - 02/04/2021
Project Topic The project will refine and validate two breakthrough innovations for early detection of Alzheimer’s disease (AD) and AD prevention and combine them into a one-stop digital medical device. The first innovation is a highly sensitive cognitive assessment method that can detect cognitive decline of presymptomatic AD. The second is artificial intelligence controlled neurogames. The ambition is to create and become the global standard of care for both presymptomatic AD detection and prevention.
Network Eurostars 2
Call Eurostars Cut–off 10

Project partner

Number Name Role Country
1 Brain+ ApS Coordinator Denmark
2 Aarhus University Partner Denmark
3 Research Institutes of Sweden, Interactive Institute AB Partner Sweden
4 Lytics Health AB Partner Sweden
5 Aarhus University Hospital Partner Denmark